ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO783

FRAX-HD: A Two-Year Incident Hip Fracture Risk Assessment Tool for Japanese Hemodialysis Patients

Session Information

Category: Dialysis

  • 607 Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular

Authors

  • Fujii, Naohiko, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan
  • Hamano, Takayuki, Osaka University Graduate School of Medicine, Suita, OSAKA-FU, Japan
  • Masakane, Ikuto, Honcho-Yabuki Clinic, Yamagata, Japan

Group or Team Name

  • Committee of Japanese Renal Data Registry, Japanese Society for Dialysis Therapy
Background

Dialysis patients are at 5-to-6-fold higher risk of hip fracture than general population. FRAX® is a useful tool for assessing future fracture risk; however, it is not optimized for hemodialysis (HD) patients. Our aim was to create a 2-year risk assessment tool for hip fracture among Japanese HD patients (FRAX_HD).

Methods

We extracted patients on facility-based HD, aged 20-100, with ≥1 yr of vintage at the end of 2007 using the Japanese nation-wide dialysis registry (JRDR-08102). Hip fractures were detected annually up to 2 years by questionnaire. We excluded patients who later received cinacalcet during the follow-up period, and randomly-selected 60%, 20%, and 20% of the eligible subjects to generate TRAIN, VALIDATE, and TEST sets, respectively. Multivariable Poisson regression analyses with interaction terms were performed to create prediction models, and validation was done later.

Results

TRAIN, VALIDATE, and TEST sets included 73999, 24667, and 24665 patients and 1574, 525, and 524 hip fractures, respectively. The subjects, aged 65.2 ± 12.3, included 39% of female and 34% of diabetes, with median vintage of 5.6 yrs. In TRAIN set, there were significant interactions between sex and age, sex and prior PTX/PEIT, and diabetes and vintage. Incidence rate ratio (IRR) elevated with age more prominently in female than in male (IRR 5.62 [95%CI: 3.32, 7.91]; females aged ≥80 vs. males aged <50). Prior history of PTX/PEIT was associated with lower risk only in female (IRR 0.58 [0.36, 0.81]). The model including these interactions demonstrated best performance and was selected as final model, which also achieved similar results in TEST set (AUC 0.739).

Conclusion

We successfully generated a 2-year risk assessment tool for hip fracture among HD patients. Further refinement and sensitivity analyses are required before its clinical application.